Saint Alphonsus in Boise earned a three-star TAVR ranking from STS and ACC, placing it among the nation’s top heart programs ...

Washington, D.C. – May 2, 2025 – New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with ...

Facing an upcoming surgical procedure often brings stress and anxiety, but not for Della de Corse. When she learned she would ...

The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement for younger adults with severe aortic stenosis rose nearly ninefold from ...

WASHINGTON, DC — New European registry data on transcatheter aortic-valve replacement (TAVR) in patients at lower surgical risk than those studied in the pivotal randomized trials offers the ...

Conscious sedation, an anesthesia procedure where patients remain awake but do not feel pain, is a safe and effective alternative to general anesthesia for transcatheter aortic valve replacement ...

PARIS -- Patients with questionable suitability for transcatheter aortic valve replacement (TAVR) in fact fared worse in the short term after the catheter-based procedure than after surgery, the ...

Edwards Lifesciences has claimed a groundbreaking approval from the FDA that opens up its minimally invasive heart valve implants to patients before they begin to show cardiac symptoms. The company ...

The US Food and Drug Administration (FDA) has approved Edwards Lifesciences' SAPIEN 3 transcatheter aortic valve replacement (TAVR) platform for the treatment of patients with asymptomatic severe ...

Delirium is more common in patients undergoing surgical rather than transcatheter aortic valve replacement (SAVR, TAVR) but predicted worse in-hospital outcomes after both procedures, a new study ...

Pulmonary hypertension patients who undergo transcatheter aortic valve replacement are at a higher risk for mortality than those without pulmonary hypertension, according to a recent study.